Skip to main content
Log in

Transdermal Delivery of Isoproterenol HC1: An Investigation of Stability, Solubility, Partition Coefficient, and Vehicle Effects

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Effects of solubility, partition coefficient, and selected adjuvants (propylene glycol and Azone) on percutaneous penetration of isoproterenol HC1 have been investigated using human cadaver skin. Isoproterenol was found to be stable (<1% decomposition) for 24 hr at 22 ± 0.5°C in the pH range 1 to 7 in the following solvents: water, normal saline, propylene glycol and a series of propylene glycol–water mixtures (10, 20, 40, and 60%; v/v); however, decomposition was significant beyond pH 8. In normal saline, the rate of decomposition increased significantly with an increase in temperature to 37°C. The solubility of isoproterenol HC1 decreased and its skin/vehicle partition coefficient increased with increasing proportions of propylene glycol in the vehicle, while the product of the solubility and partition coefficient appeared to plateau at 20% propylene glycol in water. Optimal penetration enhancing effects of Azone were seen when incorporated at a concentration of 1% (v/v) in the 20% (v/v) propylene glycol–water blend and, more significantly, when skin was pretreated with pure Azone for 60 min prior to application of the drug formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. R. Girdwood. Clinical Pharmacology, Baillier Tindall, London, 1984, pp. 21–226, 316–318.

    Google Scholar 

  2. D. Aviado. Sympathomimetic Drugs, Charles C Thomas Publisher, Springfield, Il., 1970 pp. 367–409.

    Google Scholar 

  3. C. T. Dollery, D. S. Davies, and M. E. Conolly. Arch. Int. Pharmacodyn. Ther. 192:214–219 (1971).

    Google Scholar 

  4. C. D. Morgan, C. R. J. Ruthven, and M. Sandler. Clin. Chim. Acta 26:381–386 (1969).

    Google Scholar 

  5. A. G. Ghanekar and V. Das Gupta. J. Pharm. Sci. 67:1247–1250 (1978).

    Google Scholar 

  6. The United States Pharmacopeia XX, U.S. Pharmacopoeial Convention, Rockville, Md., 1975.

  7. K. H. Valia and Y. W. Chien. Drug Dev. Indust. Pharm. 10:951–981 (1984).

    Google Scholar 

  8. S. M. Harrison, B. W. Barry, and P. H. Dugard. J. Pharm. Sci. 36:261–262 (1984).

    Google Scholar 

  9. J. Swarbrick, G. Lee, and J. Brom. J. Invest. Dermatol. 78:63–66 (1982).

    Google Scholar 

  10. B. V. Iyer and R. C. Vasavada. Int. J. Pharm. 3:247–260 (1979).

    Google Scholar 

  11. B. Mollgaard and A. Hoelgaard. Acta. Pharm. Suec. 20:433–442 (1983).

    Google Scholar 

  12. B. Mollgaard and A. Hoelgaard. Acta. Pharm. Suec. 20:443–450 (1983).

    Google Scholar 

  13. A. BenKorah and R. C. Vasavada. Master's thesis, University of the Pacific, Stockton, Calif., 1985.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, R.A., Vasavada, R.C. Transdermal Delivery of Isoproterenol HC1: An Investigation of Stability, Solubility, Partition Coefficient, and Vehicle Effects. Pharm Res 5, 116–119 (1988). https://doi.org/10.1023/A:1015996319406

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015996319406

Navigation